Prelude Therapeutics Inc (PRLD)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
308,626,000
EV to revenue ratio (TTM)
9.34
EV to ebitda
-0.54
Financial Performance
Revenue (TTM)
22,424,000
Gross profit (TTM)
22,424,000
EBITDA
-64,510,000
Profitability
Operating margin (TTM)
-270.90%
Profit margin
-269.70%
Return on assets (TTM)
-27.20%
Return on equity (TTM)
-57.70%
Per Share Metrics
Revenue per share (TTM)
0.27
EPS
-0.73
Diluted EPS (TTM)
-0.73
Book value
1.3
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
13.79
Price to book ratio (TTM)
2.569
Growth
Quarterly earnings growth (YoY)
41.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
2
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.963